Table 1.
Sample | Labeling | Buffer | Construct | NMR experiment |
---|---|---|---|---|
A1–A5a | AILMV | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~0.2 mM EIN-R1p | PRE experiment |
B | AILV | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~1 mM WT EIN | 1H–13C HMQC-NOESY-HMQC |
C | Uniformly 15N + ILV (linearized spin systems) | 5% 2H2O/95% H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~1 mM WT EIN | HC(CO)NH-TOCSY |
D | A | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~0.2 mM WT EIN | 1H–13C HMQC |
E | I | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~0.2 mM WT EIN | 1H–13C HMQC |
F | M | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~0.2 mM WT EIN | 1H–13C HMQC |
G | LV | 99.99% 2H2O, 100 mM NaCl, 0.1× EDTA-free complete protease inhibitor (Roche), and 20 mM Tris-pH 7.4 | ~0.2 mM WT EIN | 1H–13C HMQC |
All samples are in a uniform 2H, 12C and 14N background unless otherwise specified. Methyl-bearing side chains with 1H–13C labeled methyl groups are listed in the second column
The five samples correspond to R1p conjugated to surface engineered cysteines at A52C, Q87C, S113C, S196C and A241C